Zhao WL - Search Results

1

Advances in multiple omics of natural-killer/T cell lymphoma.

Xiong J, Zhao WL. Xiong J, et al. Among authors: zhao wl. J Hematol Oncol. 2018 Dec 4;11(1):134. doi: 10.1186/s13045-018-0678-1. J Hematol Oncol. 2018. PMID: 30514323 Free PMC article. Review.

2

Combined effects of histone deacetylase inhibitor and rituximab on non-Hodgkin's B-lymphoma cells apoptosis.

Zhao WL, Wang L, Liu YH, Yan JS, Leboeuf C, Liu YY, Wu WL, Janin A, Chen Z, Chen SJ. Zhao WL, et al. Exp Hematol. 2007 Dec;35(12):1801-11. doi: 10.1016/j.exphem.2007.06.009. Epub 2007 Aug 3. Exp Hematol. 2007. PMID: 17681667 Free article.

3

The prognostic value of immunohistochemical subtyping in Chinese patients with de novo diffuse large B-cell lymphoma undergoing CHOP or R-CHOP treatment.

Xia ZG, Xu ZZ, Zhao WL, Zhao SQ, Ding F, Chen Y, Chen QS, Zheng Y, Zhu Q, Hu JP, Shen ZX, Li JM. Xia ZG, et al. Among authors: zhao wl, zhao sq. Ann Hematol. 2010 Feb;89(2):171-7. doi: 10.1007/s00277-009-0799-2. Epub 2009 Aug 11. Ann Hematol. 2010. PMID: 19669764

4

Eriocalyxin B induces apoptosis in lymphoma cells through multiple cellular signaling pathways.

Zhang YW, Jiang XX, Chen QS, Shi WY, Wang L, Sun HD, Shen ZX, Chen Z, Chen SJ, Zhao WL. Zhang YW, et al. Among authors: zhao wl. Exp Hematol. 2010 Mar;38(3):191-201. doi: 10.1016/j.exphem.2009.12.005. Epub 2010 Jan 4. Exp Hematol. 2010. PMID: 20045442 Free article.

5

Proteasome inhibitor bortezomib targeted tumor-endothelial cell interaction in T-cell leukemia/lymphoma.

Shi WY, Wang L, Xiao D, Yao Y, Yang F, Jiang XX, Leboeuf C, Janin A, Chen SJ, Zhao WL. Shi WY, et al. Among authors: zhao wl. Ann Hematol. 2011 Jan;90(1):53-8. doi: 10.1007/s00277-010-1022-1. Epub 2010 Jul 9. Ann Hematol. 2011. PMID: 20617436

6

Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.

Wang L, Shi WY, Wu ZY, Varna M, Wang AH, Zhou L, Chen L, Shen ZX, Lu H, Zhao WL, Janin A. Wang L, et al. Among authors: zhao wl. J Hematol Oncol. 2010 Sep 9;3:30. doi: 10.1186/1756-8722-3-30. J Hematol Oncol. 2010. PMID: 20828385 Free PMC article.

7

Loss of promoter methylation contributes to the expression of functionally impaired PRDM1β isoform in diffuse large B-cell lymphoma.

Zhang YW, Xie HQ, Chen Y, Jiao B, Shen ZX, Chen SJ, Zhao WL. Zhang YW, et al. Among authors: zhao wl. Int J Hematol. 2010 Oct;92(3):439-44. doi: 10.1007/s12185-010-0689-3. Epub 2010 Sep 22. Int J Hematol. 2010. PMID: 20859709

8

Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients.

Xu PP, Wang Y, Shen Y, Wang L, Shen ZX, Zhao WL. Xu PP, et al. Among authors: zhao wl. Med Oncol. 2012 Sep;29(3):2176-82. doi: 10.1007/s12032-011-0011-0. Epub 2011 Jun 28. Med Oncol. 2012. PMID: 21710236

9

[Study of prognostic related factors of elderly patients with T/NK cell lymphoma].

Wang Y, Qian Y, Wu LL, Zhao BB, Xu PP, Zhao WL, Wang L. Wang Y, et al. Among authors: zhao wl, zhao bb. Zhonghua Xue Ye Xue Za Zhi. 2013 Jan;34(1):12-5. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23597457 Chinese.

10

Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma.

Dong LH, Cheng S, Zheng Z, Wang L, Shen Y, Shen ZX, Chen SJ, Zhao WL. Dong LH, et al. Among authors: zhao wl. J Hematol Oncol. 2013 Jul 18;6:53. doi: 10.1186/1756-8722-6-53. J Hematol Oncol. 2013. PMID: 23866964 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

403 results

Search Page

Filters